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Pharmacists are the medication experts and have a legal and professional 
obligation to provide medicine information to patients. However, the 
provision of information may not be necessary each time a medicine is 
supplied or dispensed and each individual patient’s or carer’s needs should be 
considered. Professional judgment therefore has to be applied regarding the 
individual’s requirements and the information should be tailored around their 
specific needs. 
Written medicines information
A Consumer Medicine Information (CMI) 
leaflet is a useful tool to be used when 
informing patients or carers about medicines. 
The importance of issuing CMI leaflets is 
reinforced by the Guidelines for pharmacists: 
Consumer Medicine Information and the 
pharmacist which recommend the provision 
of leaflets in specific instances, namely:1
•	 when a medicine is first provided to 
the patient;
•	 when brand substitution occurs and it is 
deemed appropriate;
•	 when the dosage form has been changed;
•	 with each supply of medicine for which 
regular reinforcement of information may 
be required;
•	 at the request of the patient/carer;
•	 when the patient has special needs;
•	 at regular intervals for medicines used for 
long term; and
•	 when the pharmacist has received advice 
that a sponsor has made significant 
changes to the CMI.
While CMIs do not replace counselling or 
reduce pharmacists’ duty to advise patients 
about medicines, they should be used to 
support verbal counselling. Pharmacists 
are strongly advised against withholding 
CMI leaflets.
CMIs are brand specific, must be in a specified 
format and must include specific information 
in accordance with requirements set out 
in the Therapeutic Goods Regulations 1990 
(Cth).2 During counselling, pharmacists may 
highlight parts which are particularly relevant 
to the patient and annotate the CMI with 
additional information. However, CMIs may 
not be altered or abbreviated as they are the 
official approved product documents.
In practice there could be instances when 
pharmacists may need to develop written 
medicine information resources themselves, 
for example during extemporaneous 
dispensing. In those cases it is important to 
explain to the patient or carer that the written 
information is not a CMI or is not replacing 
a CMI as a pharmacist could be open to a 
claim of negligence if a patient experiences a 
side-effect that is not covered in the written 
information. An example of such a case is the 
United States case of Cottam v CVS Pharmacy 
(2002).3 In this case the Supreme Court found 
the pharmacy 51% negligent for not warning 
a patient of priapism as a potential side-effect 
of the antidepressant trazodone; the patient 
was left permanently impotent as a result of 
using the trazodone. The court found that 
the pharmacy voluntarily assumed a duty to 
provide information, advice and warnings 
to a patient as it was the pharmacy’s normal 
practice to issue a ‘long form’ list of side-effects 
when a medicine was dispensed for the first 
time. By giving out a list of information as 
part of the pharmacy’s normal practice the 
pharmacy voluntarily assumed a duty to warn 
and in so doing had to perform that duty 
with due care. The court found that where the 
information provided could be reasonably 
understood by the patient as a complete list 
of side-effects, it is appropriate to impose the 
duty to warn as to all potential side effects.
Benefits and risks
Patients have a right to make their own 
medication management decisions but in 
order for them to do so they need sufficient 
information about treatment options and 
the likely result if treatment is not followed. 
Pharmacists should facilitate the patient or 
carer’s understanding of their medicines and 
provide information about individual medicines 
in the context of the patient’s needs, considering 
their disease conditions, social situation and 
other medicines.
It is not possible to predict outcomes or assess 
risks with certainty and pharmacists need 
to use professional judgment in explaining 
this to patients. In the landmark case of 
Rogers v Whitaker (1992)4 the Australian High 
Court made it clear that the information a 
professional ought to supply to a patient 
should be patient-focused rather than health 
practitioner-focused. The majority judgement 
of this case was based on the opinion that as 
far as technical blunders are concerned, the 
practitioner–patient relationship requires little 
contribution from the patient, as the practitioner 
should perform at a level requiring professional 
knowledge and skill. However, where 
allegations involve the provision of information 
and advice, the practitioner should provide the 
appropriate amount and level of information 
necessary for the patient to reach a decision. 
Health professionals therefore need to use their 
judgement in deciding what information to 
provide to patients and make an assessment 
as to whether the individual patient would be 
likely to attach significance to it.
Key points
Pharmacists need to counsel patients daily 
about prescribed and non-prescription 
medicines and inform patients of the benefits 
and relevant side effects as a result of taking 
the medication.
Providing medicine information is a skill 
and requires the application of professional 
judgement to ensure that the information 
provided is balanced and at an appropriate 
level for patients to understand to facilitate their 
decision-making.
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